Results 151 to 160 of about 15,068 (213)

Targeting the ANGPTL4/NRP1/ABL1/RAD51 axis reverses cisplatin resistance by impairing DNA damage repair in head and neck cancer. [PDF]

Proc Natl Acad Sci U S A
Asiedu EB, Kumar A, Choi A, Luciano DO, Lo K, Sharma D, Ma T, Rassool F, Sodhi A, Montaner S.   +9 more
europepmc   +1 more source

Epstein-Barr virus receptors: classification, functional mechanisms, and pathogenic implications. [PDF]

J Virol
Gu H, Yang S, Song L, Wang X, Zheng X, Ma J.   +5 more
europepmc   +1 more source

Hmgcs1 regulates cholesterol synthesis and promotes nerve fiber repair after spinal cord injury. [PDF]

iScience
Pei Y, Feng G, Hu Y, Tang J, Zhang N, Zhou S, Zhang C, Huang F, Zhang L.   +8 more
europepmc   +1 more source

Substitution of the SEMA3A basic domain with the VEGF₁₆₅ heparin-binding domain enhances anti-angiogenic potency in ovo. [PDF]

Biol Res
Valiulytė-Simaitė I, Šlekienė L, Balnytė I, Daukšaitė V, Tacionis S, Paškevičiūtė G, Mašalaitė K, Kazlauskas A.   +7 more
europepmc   +1 more source

Targeting Neuropilin-1 for Cancer Pain Treatment: A Trial With Potential for Clinical Translation. [PDF]

Cancer Control
Shen S, Lin A, Lan C, Xia Z, Yu M, Qiang N, Ao J, Chen G.   +7 more
europepmc   +1 more source

NCEH1 promotes breast cancer progression by regulating NRP1 and activating the TNF-α/NF-κB signalling pathway. [PDF]

Cell Adh Migr
Sun J, Liu Y, Mo J, Zhou J, Bai X, Gu B, Li J, Zhao H.   +7 more
europepmc   +1 more source

Knockout of key receptors (PDGFRA and NRP2) in the guinea pig model blocks direct and endocytic pathways of CMV cell entry. [PDF]

J Gen Virol
Qin Y, Choi KY, El-Hamdi N, McGregor A.
europepmc   +1 more source

Fibroblast-derived neuropilin 1 alleviates renal fibrosis progression. [PDF]

J Pathol
Shen Y, Placier S, Louedec L, Frère P, Vandermeersch S, Figueroa S, François H, Chadjichristos CE, Cohen C, Chatziantoniou C, Calmont A.   +10 more
europepmc   +1 more source

Semaphorins: from CD8⁺ T cells to cancer immunotherapy. [PDF]

Biomark Res
Liu Z, Wu Y, Xu P, Xu H, Yin K, Wang S.
europepmc   +1 more source